Skip to main content

Online First

Online First Meeting Highlights

ESMO 2021 Highlights

Trastuzumab Deruxtecan Tops Trastuzumab Emtansine as Second-Line Therapy in HER2-Positive Metastatic Breast Cancer

Online First Meeting Highlights

ESMO 2021 Highlights

Abiraterone Added to Androgen-Deprivation Therapy Significantly Improves Metastasis-Free Survival in Patients with High-Risk Prostate Cancer

Online First Meeting Highlights

ESMO 2021 Highlights

Adagrasib Shows Promising Activity in Metastatic Colorectal Cancer

FDA Updates

Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer

FDA Updates

Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations

FDA Updates

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

FDA Updates

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-Versus-Host Disease

FDA Updates

Jakafi a New Treatment Option for Chronic Graft-Versus-Host Disease

FDA Updates

Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer

FDA Updates

Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma

Page 6 of 14
Results 51 - 60 of 136